Head-to-head · WeighScore
Form Health vs NowPatient
By GLP-1 ScorecardUpdated
Score comparison
NowPatient has the higher recorded score — 65.5/100 to 60.6/100.
NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Form Health | NowPatient |
|---|---|---|
| WeighScore | 60.6/100 | 65.5/100 |
| Grade | C | C |
| Site position | #361 | #243 |
| Semaglutide | $1,350/mo (starting dose, brand-name) | $1,349/mo (brand Wegovy) |
| Tirzepatide | $1,350/mo (starting dose, brand-name) | $1,069/mo (brand Mounjaro, promotional rate) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #361 · C
Strengths
- Both semaglutide and tirzepatide available
- Brand-name FDA-approved medications
What to consider
- Higher brand-name pricing only
- Premium pricing relative to market
Site position #243 · C
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
What to consider
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.